The Journal of Emergency Medicine
Volume 38, Issue 4 , Pages 477-480 , May 2010

Serotonin Syndrome Precipitated by Fentanyl During Procedural Sedation

  • Ron Kirschner, MD

      Affiliations

    • Corresponding Author InformationReprint Address: Ron Kirschner, md, Central Texas Poison Center, Scott & White Memorial Hospital, 2401 S. 31 Street, Temple, TX 76508
    • ,
  • J. Ward Donovan, MD

Received 30 May 2007 ,Revised 24 December 2007 ,Accepted 27 January 2008.

References 

  1. Egan TD, Sharma A, Ashburn MA, Kievit J, Pace NL, Streisand JB. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers. Anesthesiology. 2000;92:665–673
  2. Rosow CE, Moss J, Philbin DM, Savarese JJ. Histamine release during morphine and fentanyl anesthesia. Anesthesiology. 1982;56:93–96
  3. Fahnenstich H, Steffan J, Kau N, Bartmann P. Fentanyl-induced chest wall rigidity and laryngospasm in preterm and term infants. Crit Care Med. 2000;28:836–839
  4. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434–441
  5. Giese SY, Neborsky R. Serotonin syndrome: potential consequences of Meridia combined with Demerol or fentanyl. Plast Reconstr Surg. 2001;107:293–294
  6. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007;187:361–365
  7. Mills KC. Serotonin syndrome. In:  Brent J,  Wallace K,  Burkhart K,  Phillips S,  Donovan J editor. Critical care toxicology: diagnosis and management of the critically poisoned patient. Philadelphia: Elsevier Mosby; 2005;p. 281–290
  8. Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol. 2005;28:205–214
  9. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148:705–713
  10. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635–642
  11. Ailawadhi S, Sung KW, Carlson LA, Baer MR. Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther. 2007;32:199–202
  12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245
  13. Tao R, Karnik M, Ma Z, Auerbach SB. Effects of fentanyl on 5-HT efflux involves both opioid and 5-HT1A receptors. Br J Pharmacol. 2003;139:1498–1504
  14. Roy S, Fortier L-P. Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafaxine. Can J Anaesth. 2003;50:32–35
  15. Steurenburg HJ, Claassen J, Eggers C, Hansen HC. Acute adverse reaction to fentanyl in a 55 year old man. J Neurol Neurosurg Psychiatry. 2000;69:281–282
  16. Streisand JB, Bailey PL, LeMaire L, et al. Fentanyl-induced rigidity and unconsciousness in human volunteers. Anesthesiology. 1993;78:629–634
  17. Weinger MB, Cline EJ, Smith NT, Koob GF. Ketanserin pretreatment reverses alfentanil-induced muscle rigidity. Anesthesiology. 1987;67:348–354
  18. Jin M, Gock SB, Jannetto PJ, Jentzen JM, Wong SH. Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol. 2005;29:590–598
  19. Murphy GM, Kremer C, Rodrigues HE, Schatzberg AF. Pharmacogenetics of antidepressant medication intolerance. Am J Psychiatry. 2003;160:1830–1835

PII: S0736-4679(08)00295-3

doi: 10.1016/j.jemermed.2008.01.003

The Journal of Emergency Medicine
Volume 38, Issue 4 , Pages 477-480 , May 2010

Article Tools